Zoledronic Acid Noridem

GIF decision: Marketing suspension

What does this decision mean?

  • Wstrzymanie w obrocie — The product has been temporarily suspended from circulation — sales are paused pending clarification, but it is not a full market recall.

The tested sample of Zoledronic Acid Noridem 4 mg/5 ml, concentrate for solution for infusion, failed appearance requirements due to the presence of particles visible to the naked eye in the solution. Potencjalne skutki: thromboembolic complications, vascular damage, lack of safety of intravenous therapy.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Zoledronic Acid Noridem
Risk Level
Critical
Manufacturer
Noridem Enterprises Ltd.
Batch Number
25003845
Notice Date
29.01.2026
View official statement

Related

Other Notices